Coronary Artery Stents: Appropriate Use of Adjunctive Pharmacotherapy to Prevent Stent Thrombosis

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.5, 1999-11, pp. : 341-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2209-2220

Informa Healthcare

Access to resources Recommend Favorite

The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 211-230

Adis International

Access to resources Recommend Favorite

Drug-eluting stents: synchronous with late stent thrombosis?

Reactions Weekly, Vol. 1, Iss. 1142, 2007-01 ,pp. : 3-5

Adis International

Access to resources Recommend Favorite

Drug Eluting Coronary Artery Stents

Current Drug Delivery, Vol. 7, Iss. 5, 2010-12 ,pp. : 421-427

Bentham Science Publishers

Access to resources Recommend Favorite

Sirolimus: Very late stent thrombosis, coronary artery occlusion and myocardial infarction: case report

Reactions Weekly, Vol. 1, Iss. 1385, 2012-01 ,pp. : 41-41

Adis International

Access to resources Recommend Favorite